Baluchnejadmojarad, Tourandokht <br/><br/>
Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.  [electronic resource] 

 -  Brain research  05 2017 
 - 23-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-6240 
<br/><br/><label>Standard No.: </label>10.1016/j.brainres.2017.02.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--pharmacology<br/>Apoptosis--drug effects<br/>Corpus Striatum--metabolism<br/>Dopaminergic Neurons--metabolism<br/>Ellagic Acid--metabolism<br/>Estrogen Receptor beta--antagonists & inhibitors<br/>Heme Oxygenase (Decyclizing)<br/>Malondialdehyde<br/>Models, Animal<br/>Monoamine Oxidase<br/>NF-E2-Related Factor 2<br/>Neostriatum--metabolism<br/>Neuroprotective Agents--therapeutic use<br/>Oxidative Stress--drug effects<br/>Oxidopamine--pharmacology<br/>Parkinson Disease--drug therapy<br/>Pars Compacta--metabolism<br/>Rats<br/>Reactive Oxygen Species<br/>Signal Transduction--drug effects<br/>Substantia Nigra--drug effects